Maughan, Benjamin L2; Agarwal, Neeraj3; Hussain, Syed A3; Boucher, Kenneth M3; Von Der Maase, Hans1; Kaufman, Donald S3; Lorusso, Vito3; Moore, Malcolm J3; Galsky, Matthew D3; Sonpavde, Guru3
1 Onkologisk Klinik, Finsencentret, Rigshospitalet, The Capital Region of Denmark2 University of Utah3 unknown
Weekly gemcitabine with GC every 3-4 weeks is considered conventional first-line chemotherapy for advanced urothelial carcinoma (UC). Weekly split-dose cisplatin with wGC might be less toxic and have similar activity, but has not been compared with GC. We pooled published phase II trials of GC and wGC to compare efficacy and safety.
Clinical Genitourinary Cancer (online), 2013, Vol 11, Issue 3, p. 316-20